Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
Baricitinib is effective and safe in the real-world management of severe AA, especially when initiated early in patients with lower baseline severity and elevated ESR. These findings highlight the relevance of timely intervention and appropriate patient selection.
Authors
- Manuel Sánchez‐Díaz (ORCID: https://orcid.org/0000-0002-3626-1558)
- Saionara Cristina Francisco (ORCID: https://orcid.org/0000-0002-9655-6294)
- Daniel Muñoz‐Barba (ORCID: https://orcid.org/0009-0003-8823-5575)
- Salvador Arias-Santiago
- Carmen García‐Moronta (ORCID: https://orcid.org/0009-0000-3834-8633)
Institutions
- Universidad de Granada (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
- Hospital Universitario Virgen de las Nieves (ES)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1080/09546634.2025.2583877
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00